Functional studies uncovered that the two mutant TBX20 proteins both showed significantly reduced transactivation on the target gene KCNH2 (a well-established AF-causing gene) and decreased ability to bind the promoter of KCNH2, with no effect on the nuclear distribution of TBX20. This evidence concerns the gene TBX20 and atrial fibrillation.